日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Metformin and epigenetic age in non-diabetic older people with HIV in Madrid (METFORAGING): a double-blind, randomised, placebo-controlled, pilot trial

二甲双胍与马德里非糖尿病老年 HIV 感染者的表观遗传年龄(METFORAGING):一项双盲、随机、安慰剂对照的试点试验

Gronchi, Alessandro; Hindi, Nadia; Cruz, Josefina; Blay, Jean-Yves; Lopez-Pousa, Antonio; Italiano, Antoine; Alvarez, Rosa; Gutierrez, Antonio; Rincón, Inmaculada; Sangalli, Claudia; Pérez Aguiar, Jose Luis; Romero, Jesús; Morosi, Carlo; Sunyach, Marie Pierre; Sanfilippo, Roberta; Romagosa, Cleofe; Ranchere-Vince, Dominique; Dei Tos, Angelo P; Casali, Paolo G; Martin-Broto, Javier; Liu, FangJie; Wang, DaQuan; Luo, GuangYu; Zhang, HaoTing; Liu, YiMei; Zhang, PengXin; Xia, Biao; SiTu, Yu; Wang, MengRu; Zhang, DongSheng; Hu, Yi; Wang, JunYe; Qiu, Bo; Liu, Hui; Marcelo-Calvo, Cristina; Esteban-Cantos, Andrés; Jurado, Francisco; Montejano, Rocío; Rodríguez-Centeno, Javier; Gutiérrez-García, Lucía; de Gea-Grela, Alejandro; Martínez-Martín, Patricia; Vidal, Alejandro Díez; de Miguel, Rosa; Oñoro-López, Carlos M; González, Juan Carlos; Martín-Carbonero, Luz; Bernardino, José Ignacio; Colino, Rocío Menéndez; Pérez de Villar, Noemí González; Rodés, Berta; Arribas, José Ramón

Fraction dose escalation of split-course concurrent chemoradiotherapy following induction chemo-immunotherapy in unresectable locally advanced oesophageal squamous carcinoma in China (GASTO-10102): a single-centre phase 1 study

中国一项单中心I期研究(GASTO-10102):不可切除局部晚期食管鳞状细胞癌患者诱导化疗-免疫治疗后,采用分次递增同步放化疗的剂量方案。

Liu, FangJie; Wang, DaQuan; Luo, GuangYu; Zhang, HaoTing; Liu, YiMei; Zhang, PengXin; Xia, Biao; SiTu, Yu; Wang, MengRu; Zhang, DongSheng; Hu, Yi; Wang, JunYe; Qiu, Bo; Liu, Hui

Diverse genomic and transcriptomic heterogeneity in EGFR-mutant lung adenocarcinoma between exon 19 del and exon 21 L858R

EGFR突变型肺腺癌中,外显子19缺失突变和外显子21 L858R突变之间存在多种基因组和转录组异质性。

Yang, Yuwen; Qiao, Sitan; Sun, Dongchen; Zhang, Zhonghan; Zhao, Yuanyuan; Zhan, Jianhua; Huang, Yan; Zhao, Hongyun; Yang, Yunpeng; Wu, Kui; Zhou, Xinlan; Zhang, Lanjun; Long, Hao; Yang, Haoxian; Wang, Junye; Wang, Xin; Wen, Zhesheng; Zhang, Lin; Zhang, Li; Fang, Wenfeng; Zhao, Xin; Zhang, Yaxiong

First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer: The GEMSTONE-303 Randomized Clinical Trial

一线舒格马利单抗联合化疗治疗晚期胃癌:GEMSTONE-303随机临床试验

Zhang, Xiaotian; Wang, Jufeng; Wang, Gang; Zhang, Yanqiao; Fan, Qingxia; Lu, Chuangxin; Hu, Changlu; Sun, Meili; Wan, Yiye; Sun, Sanyuan; Wang, Junye; Zhang, Li; Shu, Yongqian; Luo, Jie; Zhu, Dan; Shen, Zhenwei; Yao, Sheng; Shi, Qingmei; Yang, Jason; Shen, Lin

First-line tislelizumab and ociperlimab combined with gemcitabine and cisplatin in advanced biliary tract cancer (ZSAB-TOP): a multicenter, single-arm, phase 2 study

一线替雷利珠单抗和奥西哌利单抗联合吉西他滨和顺铂治疗晚期胆道癌(ZSAB-TOP):一项多中心、单臂、II期研究

Shi, Guoming; Huang, Xiaoyong; Ma, Liang; Li, Hui; Zhong, Jianhong; Wang, Junye; Gao, Qiang; Guo, Xiaojun; Qiu, Shuangjian; Sun, Huichuan; Shi, Yinghong; Huang, Xiaowu; Wang, Xiaoying; Yi, Yong; Zhu, Xiaodong; Huang, Cheng; Ding, Zhenbin; Chen, Yi; He, Yifeng; Shen, Yinghao; Sun, Qiman; Zhou, Jian; Fan, Jia

First-line treatment of anti-EGFR monoclonal antibody cetuximab β plus FOLFIRI versus FOLFIRI alone in Chinese patients with RAS/BRAF wild-type metastatic colorectal cancer: a randomized, phase 3 trial

在中国RAS/BRAF野生型转移性结直肠癌患者中,一线治疗方案为抗EGFR单克隆抗体西妥昔单抗β联合FOLFIRI方案与单用FOLFIRI方案的比较:一项随机、3期临床试验

Shi, Yuankai; Ba, Yi; Wang, Junye; Xiong, Jianping; Gu, Kangsheng; Chen, Yigui; Zheng, Zhendong; Wang, Zishu; Guo, Weijian; Cheng, Ying; Yin, Xianli; Liu, Yunpeng; Bai, Yuxian; Li, Enxiao; Li, Qi; Zhu, Liangjun; Li, Wei; Jiang, Da; He, Jingdong; Chen, Jiansi; Sun, Jianguo; Hou, Sheng

Targeting tumor microenvironment with biomimetic nanovesicles for non-small cell lung cancer gene therapy

利用仿生纳米囊泡靶向肿瘤微环境进行非小细胞肺癌基因治疗

Yan, Qihang; Gong, Li; Tan, Zihui; Liu, Zining; Li, Xiaodong; Liang, Dachuan; Yang, Jie; Zhang, Kai; Dai, Shuqin; Wang, Junye

Comparison of efficacy and safety of a proposed biosimilar QL1206 with reference denosumab in patients with bone metastasis from breast cancer: A subgroup analysis of a randomized, double-blinded phase III study

比较拟上市生物类似药 QL1206 与参考药物地诺单抗在乳腺癌骨转移患者中的疗效和安全性:一项随机、双盲 III 期研究的亚组分析

Liu, Yaxin; Zhang, Ruyan; Wang, Xiaojia; Di, Lijun; Chen, Zhendong; Wang, Jingfen; Sun, Tao; Li, Qingshan; Cheng, Jing; Zhang, Qingyuan; Wang, Xiuwen; Wang, Junye; Gu, Kangsheng; Wei, Shihong; Zhang, Shuqun; Wang, Xiangcai; Sun, Ping; Hao, Chunfang; Zang, Aimin; Li, Yujie; Han, Cuicui; Kang, Xiaoyan; Li, Yanling; Li, Huiping

The role of ZC3H13 in promoting M2 macrophage infiltration via m6A methylation in esophageal squamous cell carcinoma tumor progression.

ZC3H13 通过 m6A 甲基化促进 M2 巨噬细胞浸润,从而在食管鳞状细胞癌肿瘤进展中发挥作用

Yan Qihang, Xu Chendi, Gong Li, Liang Dachuan, Yang Jie, Zheng Yuzhen, Wang Junye

The Value of Dynamic of Alkaline Phosphatase and Neutrophil-to-Lymphocyte Ratio in Predicting the Efficacy of Neoadjuvant Immunochemotherapy in Patients with Non-Small Cell Lung Cancer

碱性磷酸酶动态变化和中性粒细胞/淋巴细胞比值在预测非小细胞肺癌患者新辅助免疫化疗疗效中的价值

Gong, Li; Yan, Qihang; Liang, Dachuan; Li, Liang; Yang, Jie; Wong, Wingshing; Zhang, Shuyue; Dai, Shuqin; Zhai, Wenyu; Wang, Junye